These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33292646)

  • 1. Optimising recruitment to the HAND-1 RCT feasibility study: integration of the QuinteT Recruitment Intervention (QRI).
    Husbands S; Elliott D; Davis TRC; Blazeby JM; Harrison EF; Montgomery AA; Sprange K; Duley L; Karantana A; Hollingworth W; Mills N
    Pilot Feasibility Stud; 2020 Nov; 6(1):173. PubMed ID: 33292646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimising recruitment and informed consent in randomised controlled trials: the development and implementation of the Quintet Recruitment Intervention (QRI).
    Donovan JL; Rooshenas L; Jepson M; Elliott D; Wade J; Avery K; Mills N; Wilson C; Paramasivan S; Blazeby JM
    Trials; 2016 Jun; 17(1):283. PubMed ID: 27278130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a new adapted QuinteT Recruitment Intervention (QRI-Two) for rapid application to RCTs underway with enrolment shortfalls-to identify previously hidden barriers and improve recruitment.
    Donovan JL; Jepson M; Rooshenas L; Paramasivan S; Mills N; Elliott D; Wade J; Reda D; Blazeby JM; Moghanaki D; Hwang ES; Davies L
    Trials; 2022 Apr; 23(1):258. PubMed ID: 35379301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT.
    Hamdy FC; Elliott D; le Conte S; Davies LC; Burns RM; Thomson C; Gray R; Wolstenholme J; Donovan JL; Fitzpatrick R; Verrill C; Gleeson F; Singh S; Rosario D; Catto JW; Brewster S; Dudderidge T; Hindley R; Emara A; Sooriakumaran P; Ahmed HU; Leslie TA
    Health Technol Assess; 2018 Sep; 22(52):1-96. PubMed ID: 30264692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing barriers and identifying facilitators to support informed consent and recruitment in the Cavernous malformations A Randomised Effectiveness (CARE) pilot phase trial: insights from the integrated QuinteT recruitment intervention (QRI).
    Wade J; Farrar N; Realpe AX; Donovan JL; Forsyth L; Harkness KA; Hutchinson PJA; Kitchen N; Lewis SC; Loan JJM; Stephen J; Al-Shahi Salman R;
    EClinicalMedicine; 2024 May; 71():102557. PubMed ID: 38813441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enabling recruitment success in bariatric surgical trials: pilot phase of the By-Band-Sleeve study.
    Paramasivan S; Rogers CA; Welbourn R; Byrne JP; Salter N; Mahon D; Noble H; Kelly J; Mazza G; Whybrow P; Andrews RC; Wilson C; Blazeby JM; Donovan JL
    Int J Obes (Lond); 2017 Nov; 41(11):1654-1661. PubMed ID: 28669987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer.
    Elliott D; Hamdy FC; Leslie TA; Rosario D; Dudderidge T; Hindley R; Emberton M; Brewster S; Sooriakumaran P; Catto JWF; Emara A; Ahmed H; Whybrow P; le Conte S; Donovan JL
    BJU Int; 2018 Dec; 122(6):970-977. PubMed ID: 29888845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to address recruitment to a randomised trial of surgical and non-surgical treatment for cancer: results from a complex recruitment intervention within the Mesothelioma and Radical Surgery 2 (MARS 2) study.
    Mills N; Farrar N; Warnes B; Ashton KE; Harris R; Rogers CA; Lim E; Elliott D
    BMJ Open; 2024 May; 14(5):e079108. PubMed ID: 38760029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation.
    Rooshenas L; Scott LJ; Blazeby JM; Rogers CA; Tilling KM; Husbands S; Conefrey C; Mills N; Stein RC; Metcalfe C; Carr AJ; Beard DJ; Davis T; Paramasivan S; Jepson M; Avery K; Elliott D; Wilson C; Donovan JL; ; ; ; ;
    J Clin Epidemiol; 2019 Feb; 106():108-120. PubMed ID: 30339938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple technique to identify key recruitment issues in randomised controlled trials: Q-QAT - Quanti-Qualitative Appointment Timing.
    Paramasivan S; Strong S; Wilson C; Campbell B; Blazeby JM; Donovan JL
    Trials; 2015 Mar; 16():88. PubMed ID: 25873096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-COVID-19 UK clinical trials and the COVID-19 pandemic: impact, challenges and possible solutions.
    Lorenc A; Rooshenas L; Conefrey C; Wade J; Farrar N; Mills N; Paramasivan S; Realpe A; Jepson M
    Trials; 2023 Jun; 24(1):424. PubMed ID: 37349850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011).
    Paramasivan S; Huddart R; Hall E; Lewis R; Birtle A; Donovan JL
    Trials; 2011 Mar; 12():78. PubMed ID: 21406089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework.
    Wilson C; Rooshenas L; Paramasivan S; Elliott D; Jepson M; Strong S; Birtle A; Beard DJ; Halliday A; Hamdy FC; Lewis R; Metcalfe C; Rogers CA; Stein RC; Blazeby JM; Donovan JL
    Trials; 2018 Jan; 19(1):50. PubMed ID: 29351790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to Improve Recruitment to a De-escalation Trial: A Mixed-Methods Study of the OPTIMA Prelim Trial in Early Breast Cancer.
    Conefrey C; Donovan JL; Stein RC; Paramasivan S; Marshall A; Bartlett J; Cameron D; Campbell A; Dunn J; Earl H; Hall P; Harmer V; Hughes-Davies L; Macpherson I; Makris A; Morgan A; Pinder S; Poole C; Rea D; Rooshenas L;
    Clin Oncol (R Coll Radiol); 2020 Jun; 32(6):382-389. PubMed ID: 32089356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials.
    Donovan JL; Paramasivan S; de Salis I; Toerien M
    Trials; 2014 Jan; 15():5. PubMed ID: 24393291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conveying Equipoise during Recruitment for Clinical Trials: Qualitative Synthesis of Clinicians' Practices across Six Randomised Controlled Trials.
    Rooshenas L; Elliott D; Wade J; Jepson M; Paramasivan S; Strong S; Wilson C; Beard D; Blazeby JM; Birtle A; Halliday A; Rogers CA; Stein R; Donovan JL; ; ; ; ; ;
    PLoS Med; 2016 Oct; 13(10):e1002147. PubMed ID: 27755555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The AMBER care bundle for hospital inpatients with uncertain recovery nearing the end of life: the ImproveCare feasibility cluster RCT.
    Koffman J; Yorganci E; Murtagh F; Yi D; Gao W; Barclay S; Pickles A; Higginson I; Johnson H; Wilson R; Bailey S; Ewart C; Evans C
    Health Technol Assess; 2019 Oct; 23(55):1-150. PubMed ID: 31594555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximising recruitment to a randomised controlled trial for chronic rhinosinusitis using qualitative research methods: the MACRO conversation study.
    McDermott C; Vennik J; Philpott C; le Conte S; Thomas M; Eyles C; Little P; Blackshaw H; Schilder A; Hopkins C
    Trials; 2021 Jan; 22(1):54. PubMed ID: 33436031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A feasibility study investigating the acceptability and design of a multicentre randomised controlled trial of needle fasciotomy versus limited fasciectomy for the treatment of Dupuytren's contractures of the fingers (HAND-1): study protocol for a randomised controlled trial.
    Harrison E; Tan W; Mills N; Karantana A; Sprange K; Duley L; Elliott D; Blazeby J; Hollingworth W; Montgomery AA; Davis T
    Trials; 2017 Aug; 18(1):392. PubMed ID: 28841903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Informed consent in randomised controlled trials: further development and evaluation of the participatory and informed consent (PIC) measure.
    Wade J; Humphrys E; Realpe AX; Gaunt DM; Burt J;
    Trials; 2023 May; 24(1):305. PubMed ID: 37131255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.